🇺🇸 FDA
Pipeline program

mifepristone

C-1073-14

Phase 3 small_molecule terminated

Quick answer

mifepristone for Psychotic Depression is a Phase 3 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CORCEPT THERAPEUTICS INC
Indication
Psychotic Depression
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials